The AWS ISV Accelerate Program is a co-sell program for AWS Partners who provide software solutions that run on or integrate with AWS. The AWS ISV Accelerate Program will provide The Clinician with co-sell support and benefits to connect with AWS field sellers globally, who service millions of active AWS customers. Co-selling provides better customer outcomes and assures mutual commitment from AWS and AWS Partners.

"Having established a close relationship with AWS from the start of The Clinician's journey, we are thrilled to have been accepted into the AWS ISV Accelerate Program. For us, the program will help accelerate our global business development efforts and will enable us to reach more organisations interested in digitally transforming their healthcare delivery."

Ron Tenenbaum, CEO of The Clinician

Headquartered in New Zealand with teams in Australia, Singapore, Israel and partners in MENA and the USA, The Clinician works with healthcare organisations across the globe to improve patient health outcomes and enhance care delivery by enabling the timely exchange of health data and information between patients and providers outside traditional care settings. The company's artificial intelligence (AI)-driven ZEDOC platform offers healthcare providers real-time health monitoring, analysis, and risk prediction by collecting health data directly from patients in the comfort of their own homes.

While developing ZEDOC, The Clinician joined the AWS Partner Network on the AWS Independent Software Vendor (ISV) Partner Path. By doing so, The Clinician leveraged AWS resources and programs specifically designed to meet its business goals faster, to develop its products while adhering to strict patient-data protocols.

The Princess Alexandra Hospital (PAH) in Brisbane uses the ZEDOC platform to monitor and act on post-chemotherapy side effects for lung cancer patients. ZEDOC sends a weekly questionnaire via an embedded link in a short messaging service (SMS), asking patients to report on 12 key chemotherapy-related symptoms following treatment. These responses help the hospital tailor patients' post-therapy medications or modify their next chemotherapy session accordingly.

By using ZEDOC to capture patient responses, PAH's oncology team can analyse real-time patient outcomes and actionable information, which is presented in a single, interactive dashboard. The oncology team also receives automated, real-time alerts when any oncological emergencies are reported.

Because of the improved efficiency from ZEDOC, the oncology team is able to handle increasing workloads while delivering individualised care. Furthermore, with accurate, real-time data on patient conditions, the oncology team can determine which patients can skip hospital consultations and go straight to treatment on their next visit, and who needs a doctor's review.